
Skinvisible, Inc. (SKVI)
SKVI Stock Price Chart
Explore Skinvisible, Inc. interactive price chart. Choose custom timeframes to analyze SKVI price movements and trends.
SKVI Company Profile
Discover essential business fundamentals and corporate details for Skinvisible, Inc. (SKVI) to support your stock research and investment decisions.
Sector
Consumer Defensive
Industry
Household & Personal Products
IPO Date
11 Jan 1999
Employees
2.00
Website
https://www.skinvisible.comCEO
Terry H. Howlett
Description
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company offers sunless tanning and sunscreen products under the Skinbrella name. It also licenses to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.
SKVI Financial Timeline
Browse a chronological timeline of Skinvisible, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 Aug 2025
EPS came in at -$0.05 , while revenue for the quarter reached $5.00K .
Earnings released on 14 May 2025
EPS came in at -$0.05 , while revenue for the quarter reached $5.00K .
Earnings released on 14 Apr 2025
EPS came in at $0.08 , while revenue for the quarter reached $5.00K .
Earnings released on 19 Nov 2024
EPS came in at -$0.06 , while revenue for the quarter reached $5.00K .
Earnings released on 15 Aug 2024
EPS came in at -$0.07 , while revenue for the quarter reached $5.00K .
Earnings released on 15 May 2024
EPS came in at -$0.06 , while revenue for the quarter reached $5.00K .
Earnings released on 16 Apr 2024
EPS came in at -$0.07 , while revenue for the quarter reached $5.00K .
Earnings released on 14 Nov 2023
EPS came in at -$0.06 , while revenue for the quarter reached $5.00K .
Earnings released on 14 Aug 2023
EPS came in at -$0.06 , while revenue for the quarter reached $5.00K .
Earnings released on 10 May 2023
EPS came in at -$0.33 , while revenue for the quarter reached $5.00K .
Earnings released on 29 Mar 2023
EPS came in at -$0.09 , while revenue for the quarter reached $5.00K .
Earnings released on 14 Nov 2022
EPS came in at -$0.09 , while revenue for the quarter reached $9.32K .
Earnings released on 10 Aug 2022
EPS came in at -$0.04 , while revenue for the quarter reached $205.00K .
Earnings released on 16 May 2022
EPS came in at -$0.05 , while revenue for the quarter reached $59.98K .
Earnings released on 30 Mar 2022
EPS came in at -$0.04 , while revenue for the quarter reached $252.86K .
Earnings released on 19 Nov 2021
EPS came in at -$0.04 , while revenue for the quarter reached $111.42K .
Earnings released on 16 Aug 2021
EPS came in at -$0.06 , while revenue for the quarter reached $287.10K .
Earnings released on 15 Jun 2021
EPS came in at -$0.10 , while revenue for the quarter reached $12.05K .
Earnings released on 15 Apr 2021
EPS came in at -$0.06 , while revenue for the quarter reached $132.72K .
Earnings released on 23 Nov 2020
EPS came in at -$0.09 , while revenue for the quarter reached $6.82K .
SKVI Stock Performance
Access detailed SKVI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.